 AUSTIN, Texas, March 02, 2021 GLOBE NEWSWIRE -- Lumos Pharma, Inc. NASDAQ:LUMO, a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, will present poster 7102 at the virtual Endocrine Society 2021 Annual Meeting, March 20th-23rd. LUM-201 Elicits Greater GH Response than Standard GH Secretagogues in Pediatric Growth Hormone Deficiency will be presented by authors Bright, G., MD, et al. on Saturday, March 20, 2021, at 11:00AM ET in Session P33 Growth and Growth Hormone. At that time, the poster can be accessed in the Investors Media section of our website on the Posters Presentations page under Events Presentations. 